8-K: 22nd Century Group Secures IP Rights Through 2025 with Equity Deal

22nd Century Group has entered into an agreement with North Carolina State University to settle outstanding payments and prepay future obligations through 2025, using a combination of cash and equity.

Summary

• 22nd Century Group has reached a payment agreement with North Carolina State University (NCSU) to cover outstanding payments and future obligations related to intellectual property, licensing, and sponsored research.
• The total payment of $1,220,438.34 will be made in three installments, with the company having the option to pay in cash or issue common stock.
• If shares are issued, they will be priced based on the 5-day average closing price of the company's stock prior to each payment date.
• The total number of shares issued will not exceed 19.99% of the company's outstanding shares on the agreement's effective date.
• The company will file a registration statement to allow NCSU to resell the shares.
• The agreement also extends the deadline for field trials related to a license agreement to June 1, 2026, and the deadline to initiate and/or test to June 1, 2027.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the resolution of financial obligations and securing of IP rights. However, the potential for share dilution and the need for a capital raise temper the overall sentiment.

Positives

• The agreement resolves outstanding payments and secures intellectual property rights through 2025.
• The company has the flexibility to pay in cash or equity, providing financial management options.
• The extension of field trial deadlines provides additional time for research and development.
• The agreement aligns NCSU with the company's continued success.

Negatives

• The issuance of shares could dilute existing shareholders if the company chooses to pay with equity.
• The company is required to file a registration statement for the shares, which could incur additional costs and administrative burden.
• The agreement includes a 19.99% ownership limitation, which could restrict the company's ability to issue shares in the future.

Risks

• The company may face challenges in meeting the payment deadlines if it chooses to pay in cash.
• The share price could be negatively impacted if the company issues a significant number of shares.
• There is a risk that the company may not be able to agree on alternative payment methods if the share issuance limit is reached.
• If the company fails to issue shares or remove the restrictive legend within the specified time, the agreement may be terminated.

Future Outlook

The company aims to continue its growth in the low nicotine tobacco market and expand its manufacturing capabilities. They are targeting breakeven profitability in Q1 2025.

Management Comments

• Larry Firestone, Chairman and CEO, stated that the agreement further aligns NCSU with the company's continued success.
• The company's mission is to sell the last cigarette before the 22nd Century.

Industry Context

This agreement highlights the ongoing investment in research and development within the tobacco industry, particularly in the area of reduced nicotine products. It also shows the importance of university partnerships in driving innovation.

Comparison to Industry Standards

• The agreement with NCSU is similar to other collaborations between biotech companies and universities for research and development.
• The use of equity to settle obligations is a common practice for companies in the growth phase.
• The focus on low nicotine products aligns with the industry trend towards harm reduction, similar to companies like Philip Morris International with their reduced risk products.
• The company's manufacturing capacity of 45,000,000 cartons annually is comparable to other mid-sized tobacco manufacturers.

Stakeholder Impact

• Shareholders may experience dilution if the company chooses to issue shares.
• Employees may benefit from the company's continued growth and stability.
• Customers may benefit from the company's focus on reduced nicotine products.
• Suppliers may benefit from the company's continued manufacturing operations.
• Creditors may benefit from the company's improved financial position.

Next Steps

• The company will make three payments to NCSU by January 15, 2025.
• The company will file a registration statement for the shares issued to NCSU.
• The company will continue to develop low nicotine tobacco strains and expand its manufacturing capabilities.

Key Dates

Keywords

intellectual property, licensing, sponsored research, low nicotine tobacco, equity transaction, payment agreement, NCSU, VLN, share issuance, field trials